Anglum Gregory O - 10 Feb 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
14 Feb 2022, 19:35:11 UTC
Next SEC filing
15 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Anthony D'Adamio, Attorney-in-Fact

Key filing fact

Anglum Gregory O filed Form 4 for Bioventus Inc. (BVS) on 14 Feb 2022.

Key facts

  • This page summarizes Anglum Gregory O's Form 4 filing for Bioventus Inc. (BVS).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 14 Feb 2022, 19:35.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: +$253,401.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BVS transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+65,581
Change %
+1093%
Price
Shares after
71,581
Date
10 Feb 2022
Ownership
Direct
Footnotes
F1
BVS transaction

Class A Common Stock

Tax liability

Transaction value
$253,401
Shares
+19,674
Change %
+61%
Price
$12.88
Shares after
51,907
Date
10 Feb 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BVS transaction Derivative

Phantom Profit Units

Options Exercise

Transaction value
$0
Shares
-65,581
Change %
-100%
Price
$0.000000*
Shares after
0
Date
10 Feb 2022
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
65,581
Exercise price
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .